当前位置: 首页 > 期刊 > 《中国保健营养.中旬刊》 > 20138
编号:13720914
RGD对骨肉瘤细胞MG63的抑瘤作用(2)
http://www.100md.com 2013年8月1日 李杰等
第1页

    参见附件。

     参考文献:

    [1] Sakamoto A, Iwamoto Y. Current status and perspective regarding the treatment of osteosarcoma: chemotherapy [J] . Rev Recent Clin Trials, 2008, 3( 3) : 228- 231.

    [2] Bacci G, Ferrari S, Lari S , et al. Osteosarcoma of the limb: amputation or limb salvage in patients treated by neoadjuvant chemotherapy[J] . J Bone Joint Surg Br, 2002, 84(1) : 88-92.

    [3] Humphries J D, Byron A,Humphries M J. Integrin ligands at a glance[J] J Cell Sci, 2006, 119( 19) : 3901-3903.

    [4] Jin H,Varner J.Integrins: roles in cancer development andastreatmenttargets. Br J Cancer, 2004,90: 561-565.

    [5] Kumar CC. Integrin alphavbeta3 as a therapeutic target for blocking tumor-induced angiogenesis. Curr Drug Targets,2003,4: 123-131.

    [6] von Wallbrunn A,Hltke C,Zu?hlsdorf M,et al. In vivo imaging of integrinανβ3 expression using fluorescence-mediated tomography. EurJ Nucl Med Mol Imaging,2007,34: 745-754.

    [7] Garanger E ,Boturyn D ,Dumy P. Tumor targeting with RGD peptide ligands design of new molecular conjugates for imaging and therapy of cancers[J ] . Anticancer Agents Med Chem ,2007 ,7 (5) :552-558.

    [8] Harm CA Graat, Victor W van Beusechem, Frederik HE Schagen,etal。Intravenous administration of the conditionally replicative adenovirus induces regression of osteosarcoma lung metastases. [J] .Mol Cancer. 2008; 7: 9-12.

    

您现在查看是摘要介绍页,详见PDF附件